MDxHealth SA Total Current Liabilities 2018-2025 | MDXH

MDxHealth SA total current liabilities from 2018 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
MDxHealth SA Annual Total Current Liabilities
(Millions of US $)
2024 $43
2023 $20
2022 $18
2021 $16
2020 $13
2019 $10
2018 $11
2017 $13
2016 $0
MDxHealth SA Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $43
2024-12-31 $43
2024-09-30 $46
2024-06-30 $45
2023-12-31 $20
2023-09-30 $19
2023-06-30
2023-03-31 $19
2022-12-31
2022-09-30
2022-06-30 $21
2022-03-31
2021-12-31 $16
2021-06-30 $12
2020-12-31 $13
2020-06-30 $10
2019-12-31 $10
2019-06-30 $8
2018-12-31 $11
2017-12-31 $13
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.101B $0.090B
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.136B 58.95
Hims & Hers Health (HIMS) United States $12.000B 124.67
Tempus AI (TEM) United States $10.868B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $4.068B 63.55
Hinge Health (HNGE) United States $3.121B 0.00
Privia Health (PRVA) United States $2.805B 191.75
Enovis (ENOV) United States $1.818B 10.14
Schrodinger (SDGR) United States $1.741B 0.00
Clover Health Investments (CLOV) United States $1.567B 0.00
Phreesia (PHR) United States $1.501B 0.00
Omnicell (OMCL) United States $1.466B 25.86
Azenta (AZTA) United States $1.310B 60.89
10x Genomics (TXG) United States $1.150B 0.00
Fulgent Genetics (FLGT) United States $0.648B 0.00
Claritev (CTEV) United States $0.605B 0.00
Butterfly Network (BFLY) United States $0.591B 0.00
Talkspace (TALK) United States $0.553B 165.25
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Outset Medical (OM) United States $0.342B 0.00
Health Catalyst (HCAT) United States $0.275B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.130B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
American Well (AMWL) United States $0.108B 0.00
CareCloud (CCLD) United States $0.091B 3.45
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00